Core Viewpoint - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. plans to spin off its subsidiary, Fosun Antigen (Chengdu) Biopharmaceutical Co., Ltd., for a listing on the Hong Kong Stock Exchange, which is expected to maintain the company's control over the subsidiary after the split [1][6]. Group 1: Spin-off Details - The board of directors approved the spin-off proposal during a meeting held on January 22, 2026, with unanimous support from all directors [5][7]. - The spin-off is subject to various approvals, including from the company's shareholders and regulatory bodies, which introduces uncertainty regarding the timeline and feasibility of the listing [2][9]. Group 2: Financial and Operational Aspects - Fosun Antigen has reported net profits of RMB 3.731 billion, RMB 2.011 billion, and RMB 2.314 billion for the years 2022, 2023, and 2024 respectively, indicating consistent profitability over the last three years [21]. - The cumulative net profit attributable to the parent company, after excluding the subsidiary's losses, is RMB 8.076 billion, exceeding the required RMB 600 million [21][22]. Group 3: Strategic Rationale - The spin-off aims to enhance the focus on the vaccine business, which is positioned as a core area of growth amid increasing demand for innovative vaccines [40][41]. - By establishing Fosun Antigen as an independent entity, the company seeks to optimize resource allocation and improve operational efficiency, thereby enhancing competitiveness in the vaccine market [42][43]. Group 4: Market Position and Future Prospects - The spin-off is expected to unlock the valuation potential of Fosun Antigen, allowing for clearer financial analysis and potentially better market pricing [44]. - The move is aligned with the company's internationalization strategy, leveraging Hong Kong's status as a financial hub to attract global investment and partnerships [45].

Core Viewpoint - Zhejiang Dahua Technology Co., Ltd. plans to adjust the listing location of its subsidiary, Zhejiang Huari Technology Co., Ltd., from domestic exchanges to the Hong Kong Stock Exchange, aiming to enhance financing capabilities and brand effect [1][2]. Group 1: Overview of the Spin-off - The proposal to spin off Huari Technology was initially aimed at a domestic exchange but has now shifted to the Hong Kong Stock Exchange due to various strategic considerations [2]. - The spin-off will allow the company to maintain control over Huari Technology while enhancing its financing capabilities and competitive advantages in the market [2]. Group 2: Business Focus of Huari Technology - Huari Technology specializes in machine vision and mobile robotics, providing comprehensive product solutions and system services through industrial internet technologies [2]. Group 3: Authorization and Governance - The board of directors has authorized the management of both the company and Huari Technology to initiate preparatory work for the spin-off, including hiring intermediaries and drafting the listing plan [3]. - Independent directors and the supervisory board support the spin-off, believing it will optimize resource allocation and broaden financing channels for Huari Technology [3].

Core Viewpoint - The article discusses the planned spin-off of Zijin Mining Group's subsidiary, Zijin Gold International, for listing on the Hong Kong Stock Exchange, along with the independent financial advisor's review of insider trading activities related to this event [1][6]. Summary by Sections Spin-off Plan - Zijin Mining Group intends to spin off its subsidiary, Zijin Gold International, for a listing on the Hong Kong Stock Exchange [1]. - The spin-off is subject to various regulations, including the "Rules on Spin-off of Listed Companies" and "Management Measures for Major Asset Restructuring of Listed Companies" [1]. Insider Information Review - The review period for insider trading activities spans from October 29, 2024, to May 26, 2025, covering six months prior to the disclosure of the spin-off plan [1]. - The scope of the review includes current directors, supervisors, senior management, and related personnel of both the parent company and the subsidiary, as well as major shareholders and relevant intermediaries [1]. Trading Activities - During the review period, the following trading activities were noted: - CITIC Securities, as the independent financial advisor, reported buying 189,102,677 shares and selling 151,307,982 shares of Zijin Mining [1]. - Other trading activities by related personnel were also documented, with specific buy and sell figures provided [1][2]. Compliance and Commitments - The independent financial advisor established an "Information Barrier System" to prevent insider trading and ensure compliance with regulations [1]. - Relevant personnel and their immediate family members provided declarations stating that their trading activities were based on market information and personal judgment, with no connection to the spin-off [2][3][4]. Conclusion of Review - The independent financial advisor concluded that the trading activities during the review period did not constitute insider trading as defined by relevant laws, and thus do not pose a legal obstacle to the spin-off [5][6].

公司注册地四川省成都市，成立于2016年4月20日，于2023年1月10日在全国股份转让系统挂牌，于2023年9月调至创新层。公司证券简称为"开发科技"，证券代码 为"873879"，公司目前注册资本10,040万元。 截止最新披露，发行人的实际控制人为中国电子，其通过深科技控制公司股份数量为7,000万股，占本次发行前总股本的比例为69.72%。 一、2023年净利润4.86亿，2024年预测逾5.4亿净利 公司主营业务为智能电、水、气表等智能计量终端以及AMI系统软件的研发、生产及销售。公司是全球最早参与智能电表研发及部署的企业之一。 2021年、2022年、2023年及2024年1-6月，公司境外市场贡献的主营业务收入分别为142,261.50万元、156,977.39万元、209,614.19万元及121,433.14万元，占公司主 营业务收入的比例分别达到96.90%、87.70%、82.27%及92.15%。 文/梧桐兄弟 成都长城开发科技股份有限公司（873879）申报北交所IPO于2023年12月12日获得受理，现已完成三轮问询。公司本次IPO拟募资10.17亿元。 | 项目 | 2024年6 ...